Avoiding radical surgery after pre-operative chemoradiotherapy: A possible therapeutic option in rectal cancer?

Acta Oncologica

Volumn 51, Issue 3, 2012, Pages 275-284

  Hingorani, Mohan ^a   Hartley, John E ^a   Greenman, John ^a   MacFie, John ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; EXCISION; HISTOPATHOLOGY; HUMAN; LONG COURSE PREOPERATIVE RADIOTHERAPY; MEDLINE; NEOADJUVANT LONG COURSE CHEMORADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ALGORITHMS; CHEMORADIOTHERAPY; HUMANS; PREOPERATIVE CARE; RECTAL NEOPLASMS; WATCHFUL WAITING;

EID: 84859746616     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.636756     Document Type: Review

References (46)

1. Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev 2009; CD006041.
2. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-23.
3. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. New Eng. J. Med. 2006;355:1114-23.
4. Marks G, Mohiuddin MM, Masoni L, Pecchioli L. High-dose preoperative radiation and full-thickness local excision. A new option for patients with select cancers of the rectum. Dis Colon Rectum 1990;33:735-9.
5. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: A new option for selected T3 distal rectal cancers. Int. J. Radiat. Oncol. Biol. Phys. 1994;30:845-9.
6. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, et al. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann. Surg. Oncol 2010;17:441.
7. Kundel Y, Brenner R, Purim O, Peled N, Idelevich E, Fenig E, et al. Isocal excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option? Dis Colon Rectum 2010; 53:1624-31.
8. Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW Vauthey JN, Copeland EM 3rd., et al. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 2002;194:584.
9. Ruo L, Guillem JG, Minsky BD, Quan SH, Paty PB, Cohen AM. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int. J. Colorectal Dis 2002;17:54.
10. Kim CJ, Yeatman TJ, Coppola D, Trotti A, Williams B, Barthel JS, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann. Surg. 2001;234:352.
11. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2004; 60:1098.
12. Huh JW, Jung EJ, Park YA, Lee KY, Sohn SK. Preoperative chemoradiation followed by transanal excision for rectal cancer. J Surg Res 2008;148:244-50.
13. Nair RM, Siegel EM, Chen DT, Fulp WJ, Yeatman TJ, Malafa MP, et al. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg 2008;12:1797 - 805; discussion 1805 - 6. Epub 2008 Aug 15.
14. Borschitz T, Wachtlin D, Möh ler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann. Surg. Oncol 2008;15:712.
15. Guerrieri M, Baldarelli M, Organetti L, Grillo Ruggeri F, Mantello G, Bartolacci S, et al. Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc 2008; 22:2030-5.
16. Lezoche G, Baldarelli M, Guerrieri M, Paganini AM, De Sanctis A, Bartolacci S, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 2008; 22:352-8.
17. Bujko K, Richter P, Kol odziejczyk M, Nowacki MP, Kulig J, Popiela T, et al. Polish Colorectal Study Group. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 2009;92:195-201. Epub 2009 Mar 16.
18. De Campos-Lobato LF, Stocchi L, da Luz Moreira A, Geisler D, Dietz DW, Lavery IC, et al. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann. Surg. Oncol Epub 2011 Jan 5.
19. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann. Surg. 2004;240:711.
20. Habr-Gama A. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis 2006;8(Suppl 3):21.
21. Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006;10:1319 - 28; discussion 1328-9.
22. Hughes R, Harrison M, Glynne-Jones R. Could a wait and see policy be justifi ed in T3/4 rectal cancers after chemoradiotherapy? Acta. Oncol. 2010;49:378-81.
23. Winde G, Nottberg H, Keller R, Schmid KW, Bünte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996;39:969-76.
24. Mignanelli ED, De Campos-Lobato LF, Stocchi L, Lavery IC, Dietz DW. Downstaging after chemoradiotherapy for locally advanced rectal cancer: Is there more (tumor) than meets the eye? Dis. Colon. Rectum. 2010;53:251-6.
25. Bedrosian I, Rodriquez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, et al. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 2004;8:56-63.
26. Guillem J, Chessin D, Shia J, Moore HG, Mazumdar M, Bernard B, et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 2005;23:3475-9.
27. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. J Am Coll Surg 2002;194:131.
28. dos Santos LV, dos Anjos Jác ome AA, Cár cano FM, da Silveira Nogueira Lima JP, Serrano SV. Watch and wait policy remains experimental for the management of rectal cancer. Colorectal Dis 2010;12:833.
29. Kalady MF, De Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann. Surg. Epub 2009 Aug 25.
30. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: Does delayed surgery have an impact on outcome? Int. J. Radiat. Oncol. Biol. Phys. 2008;71:1181-8.
31. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM. Optimal timing of surgery after chemoradiation for advanced rectal cancer: Preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann. Surg. 2011;254:97-102.
32. Hopkins S, Fakih M, Yang GY. Positron emission tomography as predictor of rectal Cancer Response during or following neoadjuvant chemoradiation. World J Gastrointest Oncol 2010;2:213-7.
33. Capirci C, Rubello D, Chierichetti F, Crepaldi G, Carpi A, Nicolini A, et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: Role of F18-FDG PET. Biomed Pharmacother 2004;58:451-7.
34. Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009;250:730-9.
35. Mardor Y, Roth Y, Ochershvilli A, Spiegelmann R, Tichler T, Daniels D, et al. Pretreatment prediction of brain tumors 'response to radiation therapy using high b-value diffusionweighted MRI. Neoplasia 2004;6:136-42.
36. Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusionweighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010;254:170-8. Epub 2009 Dec 17.
37. Capirci C, Rubello D, Chierichetti F, Crepaldi G, Fanti S, Mandoliti G, et al. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. AJR Am. J. Roentgenol 2006;187:W202 - 8.
38. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007;34:1583-93.
39. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004;31:811-9.
40. Rosenberg R, Herrmann K, Gertler R, K ünzli B, Essler M, Lordick F, et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int. J. Colorectal Dis 2009; 24:191-200.
41. Konski A, Li T, Sigurdson E, Cohen SJ, Small W Jr, Spies S, et al. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int. J. Radiat. Oncol. Biol. Phys. 2009;74: 55-9.
42. J anssen MH, Ollers MC, Van Stiphout RG, Riedl RG, Van Den Bogaard J, Buijsen J, et al. PET-based treatment response evaluation in rectal cancer: Prediction and validation. Int. J. Radiat. Oncol. Biol. Phys. Epub 2011 Mar 5.
43. Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X, et al. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta. Oncol. 2010;49:956-63.
44. Wlodkowic D, Cooper JM. Tumors on chips; oncology meets microfl uidics. Curr Op Chem Biol 2010;14:1-12.
45. Webster A, Greenman J, Haswell SJ. Development of microfl uidic devices for biomedical and clinical application. J Chem Technol Biotechnol 2010. DOI 10.1002/jctb.2482.
46. Webster A, Dyer CE, Haswell SJ, Greenman J. A microfl uidic device for tissue biopsy culture and interrogation. Anal Methods 2010;2:1005-7.